35th Symposium on Medicinal Chemistry in Eastern England

THE VENUE HAS NOW CHANGED AND MEETING WILL TAKE PLACE IN GSK CONFERENCE CENTRE

Event
35th Symposium on Medicinal Chemistry in Eastern England

Dates
Thursday, 25th April 2024

Place
GSK Conference Centre, Stevenage

Important links
X hashtag – #MedChemSymp24
To register as sponsor, please click here
To download first announcement poster, click here
To download second announcement poster, click here

Synopsis
Known colloquially as the “Hatfield MedChem” meeting*, this is a highly successful, long-standing, one-day meeting that runs annually. The scientific program will comprise presentations showcasing medicinal chemistry case studies from tools to candidates, across a range of modalities, therapeutic areas and target classes, as well as covering more general topics at the forefront of drug discovery. The meeting aims to be informal and interactive, and is ideal for all those working in medicinal chemistry and drug discovery more widely.

*Please note the change of venue for 2024. The 35^th meeting will be held at GSK Conference Centre, Stevenage, SG1 2NY

Call for Oral abstracts
Abstract submission for Oral abstracts are now closed!

Programme

09:00	REGISTRATION / COFFEE
	MORNING SESSION Chair: Alison Jones (Charles River)
09:30	Welcome and Introduction
09:35	Discovery of insurmountable MC2 receptor antagonists for the treatment of diseases caused by excess ACTH Laia Malet Sanz (OMass Therapeutics)
10:15	RNA-Splicing modulators for the treatment of Huntington’s disease Karine Malagu (Charles River)
10:55	REFRESHMENTS
11:25	Discovery and characterisation of human DNA polymerase theta inhibitors Robert Heald (Artios Pharma)
11:50	Fragment-based discovery of allosteric SHP2 inhibitors Rhian Holvey (Astex)
12:15	Application of AI augmented drug design to oncology drug discovery projects Samantha Hughes (Astra Zeneca)
12:45	LUNCH
	AFTERNOON SESSION Chair: Simon Ward (Medicines Discovery Institute, Cardiff University)
13:50	CAPPS GREEN ZOMAYA AWARD LECTURE: Tackling challenging drug targets as a pathway to antibiotics with a novel mode of action Anna Hirsch (Helmholtz Institute for Pharmaceutical Research Saarland)
14:35	Discovery of CVN293, a blocker of KCNK13, a novel microglial target for neurodegenerative diseases Andrew Stott (Cerevance)
15:15	REFRESHMENTS
15:45	The discovery and early development of a long-acting antimalarial MMV533 Stephen Brand (Medicines for Malaria Venture)
16:15	Application of a human cell-based phenotypic assay to identify small molecule capable of restoring cytokine balance in inflammatory disorders Simon Nicolle (GSK)
16:55	Concluding Remarks
17:00	Meeting close

Registration
Registration is NOW FULLY BOOKED

Registration Fees
RSC Member* £150
Non-Member £200
RSC Student ** Member* (Undergraduate and post-graduate) £75
Student** Non-Member (Undergraduate and post-graduate) £98
RSC Unemployed Member £45
Unemployed Non-Member £75
Retired Member £45

* Member is a paid-up member of the RSC
** Student rates apply to undergraduate and post-graduate students only, but not post-doctoral students.

Sponsorship/exhibition opportunities
EXHIBITION STANDS ARE NOW FULLY BOOKED

– A six foot trestle table and chairs
– Access to electricity and wi-fi
– Logo inclusion in pdf of delegate handbook, website and rolling slides
– Exhibitors promotional page in a pdf delegate handbook
– One stand personnel with access to technical sessions

We are also seeking sponsorship from organisations supporting the low registration fees offered to students. You can support and sponsor this meeting by clicking the booking link above.

Sponsors
We are grateful to our confirmed sponsors for their valued support